Opioid induced hyperalgesia in anesthetic settings

Korean Journal of Anesthesiology

Volumn 67, Issue 5, 2014, Pages 299-304

  Lee, Hyeon Jeong ^a,b   Yeomans, David C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Hyperalgesia; Opioid Analgesics; Postoperative pain

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRENORPHINE; CHOLECYSTOKININ; DEXTROMETHORPHAN; DYNORPHIN; G PROTEIN COUPLED RECEPTOR; KETAMINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE FF; NOCICEPTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROSTAGLANDIN SYNTHASE INHIBITOR; REMIFENTANIL;

ACTION POTENTIAL; ANALGESIA; HUMAN; HYPERALGESIA; META ANALYSIS (TOPIC); NOCICEPTION; NONHUMAN; PAIN THRESHOLD; POSTOPERATIVE PAIN; REVIEW; SIGNAL TRANSDUCTION;

EID: 84914156169     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2014.67.5.299     Document Type: Review

References (44)

1. Tompkins DA, Campbell CM. Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? Curr Pain Headache Rep 2011; 15: 129-36.
2. Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005; 103: 147-55.
3. Andrews HL. The effect of opiates on the pain threshold in post-addicts. J Clin Invest 1943; 22: 511-6.
4. Tilson HA, Rech RH, Stolman S. Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 1973; 28: 287-300.
5. Sufka KJ, Hughes RA, Giordano J. Effects of selective opiate antagonists on morphine-induced hyperalgesia in domestic fowl. Pharmacol Biochem Behav 1991; 38: 49-54.
6. Hughes RA, Bowes M, Sufka KJ. Morphine hyperalgesic effects on developmental changes in thermal nociception and respiration in domestic fowl (Gallus gallus). Pharmacol Biochem Behav 1992; 42: 535-9.
7. Sufka KJ, Hoganson DA, Hughes RA. Central monoaminergic changes induced by morphine in hypoalgesic andhyperalgesic strains of domestic fowl. Pharmacol Biochem Behav 1992; 42: 781-5.
8. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93: 409-17.
9. Baron MJ, McDonald PW. Significant pain reduction in chronic pain patients after detoxification from high-dose opioids. J Opioid Manag 2006; 2: 277-82.
10. Carroll IR, Angst MS, Clark JD. Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med 2004;29: 576-91.
11. Eisenberg E, Midbari A, Haddad M, Pud D. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects. Pain 2010; 151: 104-9.
12. Celerier E, Laulin JP, Corcuff JB, Le Moal M, Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci 2001; 21: 4074-80.
13. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994; 14: 2301-12.
14. Mao J, Sung B, Ji RR, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002; 22: 7650-61.
15. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62: 259-74.
16. Rivat C, Laulin JP, Corcuff JB, Celerier E, Pain L, Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 2002; 96: 381-91.
17. Heinricher MM, Morgan MM, Tortorici V, Fields HL. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 1994; 63: 279-88.
18. Vanderah TW, Ossipov MH, Lai J, Malan TP Jr, Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 2001; 92: 5-9.
19. Eguchi M. Recent advances in selective opioid receptor agonists and antagonists. Med Res Rev 2004; 24: 182-212.
20. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995; 18: 22-9.
21. Heinricher MM, Morgan MM, Fields HL. Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 1992; 48: 533-43.
22. Ernst OP, Gramse V, Kolbe M, Hofmann KP, Heck M. Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc Natl Acad Sci U S A 2007; 104: 10859-64.
23. Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 2003; 64: 1317-24.
24. Vilardaga JP, Nikolaev VO, Lorenz K, Ferrandon S, Zhuang Z, Lohse MJ. Conformational cross-talk between alpha2A-adrenergic and muopioid receptors controls cell signaling. Nat Chem Biol 2008; 4: 126-31.
25. Cesselin F. Opioid and anti-opioid peptides. Fundam Clin Pharmacol 1995; 9: 409-33.
26. Yuan L, Han Z, Chang JK, Han JS. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res 1999; 826: 330-4.
27. Wiesenfeld-Hallin Z, Xu XJ. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Regul Pept 1996; 65: 23-8.
28. Jensen KB, Lonsdorf TB, Schalling M, Kosek E, Ingvar M. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One 2009; 4: e6016.
29. Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth 2014; 112: 991-1004.
30. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006; 104: 570-87.
31. Cabanero D, Campillo A, Celerier E, Romero A, Puig MM. Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 2009; 111: 1334-45.
32. Shin SW, Cho AR, Lee HJ, Kim HJ, Byeon GJ, Yoon JW, et al. Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br J Anaesth 2010; 105: 661-7.
33. Drdla R, Gassner M, Gingl E, Sandkuhler J. Induction of synaptic long-term potentiation after opioid withdrawal. Science 2009; 325: 207-10.
34. Echevarria G, Elgueta F, Fierro C, Bugedo D, Faba G, Iniguez-Cuadra R, et al. Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br J Anaesth 2011; 107: 959-65.
35. Singler B, Troster A, Manering N, Schuttler J, Koppert W. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth Analg 2007; 104: 1397-403.
36. Koppert W, Ihmsen H, Korber N, Wehrfritz A, Sittl R, Schmelz M, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 2005; 118: 15-22.
37. Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000; 20: 7074-9.
38. Davis MP, Shaiova LA, Angst MS. When opioids cause pain. J Clin Oncol 2007; 25: 4497-8.
39. Gu X, Wu X, Liu Y, Cui S, Ma Z. Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine. Mol Pain 2009; 5: 76.
40. Compton PA, Ling W, Torrington MA. Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadonemaintained patients. Addict Biol 2008; 13: 393-402.
41. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998; 391: 281-5.
42. Gowing LR, Farrell M, Ali RL, White JM. Alpha2-adrenergic agonists in opioid withdrawal. Addiction 2002; 97: 49-58.
43. Ohnesorge H, Feng Z, Zitta K, Steinfath M, Albrecht M, Bein B. Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice. PLoS One 2013; 8: e79567.
44. Belgrade M, Hall S. Dexmedetomidine infusion for the management of opioid-induced hyperalgesia. Pain Med 2010; 11: 1819-26.